Viviane Tabar

24.7k total citations · 9 hit papers
153 papers, 13.1k citations indexed

About

Viviane Tabar is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Viviane Tabar has authored 153 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 49 papers in Molecular Biology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Viviane Tabar's work include Glioma Diagnosis and Treatment (55 papers), Brain Metastases and Treatment (33 papers) and Pluripotent Stem Cells Research (30 papers). Viviane Tabar is often cited by papers focused on Glioma Diagnosis and Treatment (55 papers), Brain Metastases and Treatment (33 papers) and Pluripotent Stem Cells Research (30 papers). Viviane Tabar collaborates with scholars based in United States, Canada and Italy. Viviane Tabar's co-authors include Lorenz Studer, Cameron Brennan, Georgia Panagiotakos, Philip H. Gutin, Tiziano Barberi, Yechiel Elkabetz, Yosif Ganat, Ron McKay, Koos E. Hovinga and Neil L. Harrison and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Viviane Tabar

148 papers receiving 12.9k citations

Hit Papers

Dopamine neurons derived from human ES cells efficiently ... 2004 2026 2011 2018 2011 2010 2004 2009 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease
    2011 1.4k citations Viviane Tabar, Lorenz Studer et al. Nature profile →
  2. Glioblastoma stem-like cells give rise to tumour endothelium
    2010 944 citations Cameron Brennan, Viviane Tabar et al. Nature profile →
  3. Derivation of midbrain dopamine neurons from human embryonic stem cells
    2004 747 citations Viviane Tabar, Lorenz Studer et al. Proceedings of the National Academy of Sciences profile →
  4. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs
    2009 649 citations Viviane Tabar, Lorenz Studer et al. Nature profile →
  5. Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
    2020 618 citations Cameron Brennan, Viviane Tabar et al. profile →
  6. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage
    2008 520 citations Viviane Tabar, Lorenz Studer et al. profile →
  7. Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
    2016 430 citations Cameron Brennan, Viviane Tabar et al. profile →
  8. Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
    2015 306 citations Christopher A. Barker, Viviane Tabar et al. profile →
  9. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
    2025 25 citations Viviane Tabar, Harini Sarva et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viviane Tabar United States 45 7.9k 3.1k 2.5k 2.1k 2.0k 153 13.1k
Eugenio Parati Italy 46 4.5k 0.6× 2.2k 0.7× 1.6k 0.6× 1.8k 0.8× 2.1k 1.0× 188 9.6k
Harley I. Kornblum United States 59 6.7k 0.8× 2.1k 0.7× 2.5k 1.0× 2.1k 1.0× 2.5k 1.3× 158 11.7k
Rossella Galli Italy 35 6.6k 0.8× 3.2k 1.0× 2.4k 1.0× 2.8k 1.3× 4.4k 2.2× 74 12.5k
Angelo L. Vescovi Italy 59 10.3k 1.3× 5.1k 1.7× 4.0k 1.6× 4.0k 1.9× 5.4k 2.7× 190 18.7k
William B. Stallcup United States 63 6.8k 0.9× 1.4k 0.4× 2.6k 1.0× 1.4k 0.7× 2.2k 1.1× 146 13.0k
Brent A. Reynolds United States 43 8.5k 1.1× 3.7k 1.2× 4.2k 1.7× 2.9k 1.4× 7.5k 3.7× 98 15.6k
Karl H. Plate Germany 68 10.8k 1.4× 2.6k 0.8× 1.4k 0.6× 3.1k 1.5× 785 0.4× 159 17.1k
Scott R. VandenBerg United States 56 4.8k 0.6× 4.5k 1.5× 899 0.4× 1.7k 0.8× 1.3k 0.7× 152 11.9k
Nader Sanai United States 53 2.4k 0.3× 6.0k 1.9× 1.5k 0.6× 885 0.4× 2.2k 1.1× 192 12.8k
Dennis A. Steindler United States 52 4.7k 0.6× 1.8k 0.6× 3.4k 1.4× 1.5k 0.7× 3.8k 1.9× 129 10.2k

Countries citing papers authored by Viviane Tabar

Since Specialization
Citations

This map shows the geographic impact of Viviane Tabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viviane Tabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viviane Tabar more than expected).

Fields of papers citing papers by Viviane Tabar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viviane Tabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viviane Tabar. The network helps show where Viviane Tabar may publish in the future.

Co-authorship network of co-authors of Viviane Tabar

This figure shows the co-authorship network connecting the top 25 collaborators of Viviane Tabar. A scholar is included among the top collaborators of Viviane Tabar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viviane Tabar. Viviane Tabar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabar, Viviane, Harini Sarva, Andrés M. Lozano, et al.. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature. 641(8064). 978–983. 25 indexed citations breakdown →
2.
Reiner, Anne S., et al.. (2025). Prospective Assessment of Mood and Quality of Life in Cushing Syndrome Before and After Biochemical Control. The Journal of Clinical Endocrinology & Metabolism.
3.
Lin, Andrew, Vasilisa A. Rudneva, Nazanin Majd, et al.. (2025). Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 110(11). 3066–3073. 5 indexed citations
4.
Stickels, Robert R., Catherine Snopkowski, Kenny Kwok Hei Yu, et al.. (2025). Transcript-specific enrichment enables profiling of rare cell states via single-cell RNA sequencing. Nature Genetics. 57(2). 451–460. 7 indexed citations
5.
Reiner, Anne S., Matthew Pease, Tejus Bale, et al.. (2024). Development and prospective validation of an artificial intelligence-based smartphone app for rapid intraoperative pituitary adenoma identification. SHILAP Revista de lepidopterología. 4(1). 45–45. 3 indexed citations
6.
Saito, Yuhki, Misa Saito, Christopher Y. Park, et al.. (2024). NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells. Proceedings of the National Academy of Sciences. 121(10). e2314695121–e2314695121. 2 indexed citations
7.
Fasano, Alfonso, Claire Henchcliffe, Harini Sarva, et al.. (2024). Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study. Parkinsonism & Related Disorders. 122. 106129–106129.
8.
Tabar, Viviane, Kenny Kwok Hei Yu, Andrés M. Lozano, et al.. (2024). 510 Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: Results From a Phase 1 Study of Bemdaneprocel. Neurosurgery. 70(Supplement_1). 156–156. 1 indexed citations
9.
Tabar, Viviane & Roger A. Barker. (2024). Sham surgery for the trialing of cell-based therapies to the CNS may not be necessary. Cell stem cell. 31(2). 158–160. 2 indexed citations
10.
Lin, Andrew, Eliza B. Geer, Gabrielle Page‐Wilson, et al.. (2023). The treatment of aggressive prolactinomas with everolimus. Pituitary. 26(4). 474–481. 7 indexed citations
11.
Lin, Andrew, Viviane Tabar, Robert J. Young, & Eliza B. Geer. (2023). Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma. Pituitary. 26(4). 482–487. 9 indexed citations
12.
Lin, Andrew, Viviane Tabar, Robert J. Young, et al.. (2021). Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma. Journal of the Endocrine Society. 5(10). bvab133–bvab133. 30 indexed citations
13.
Lohia, Shivangi, Christopher A. Barker, Jennifer R. Cracchiolo, et al.. (2020). Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma. Head & Neck. 42(11). 3316–3325. 5 indexed citations
14.
Lin, Andrew, Mark T.A. Donoghue, Sharon L. Wardlaw, et al.. (2020). Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor. The Journal of Clinical Endocrinology & Metabolism. 105(12). 3807–3820. 15 indexed citations
15.
Imber, Brandon S., Andrew Lin, Zhigang Zhang, et al.. (2019). Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?. Journal of the Endocrine Society. 3(9). 1693–1706. 22 indexed citations
16.
Bathla, Girish, et al.. (2019). Resting State Functional Connectivity of the Supplementary Motor Area to Motor and Language Networks in Patients with Brain Tumors. Journal of Neuroimaging. 29(4). 521–526. 11 indexed citations
17.
Xiao, Roy, Qasim Husain, Jennifer R. Cracchiolo, et al.. (2019). Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach. Head & Neck. 41(10). 3551–3563. 15 indexed citations
18.
Husain, Qasim, Benjamin R. Roman, Jennifer R. Cracchiolo, et al.. (2018). Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. Journal of Surgical Oncology. 119(1). 130–142. 31 indexed citations
19.
Pulvirenti, Teodoro, et al.. (2011). Dishevelled 2 Signaling Promotes Self-Renewal and Tumorigenicity in Human Gliomas. Cancer Research. 71(23). 7280–7290. 82 indexed citations
20.
Evers, Mark B., Irving L. Weissman, Alan W. Flake, Viviane Tabar, & Richard D. Weisel. (2003). Stem Cells in Clinical Practice. Journal of the American College of Surgeons. 197(3). 458–478. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenio Parati Breakdown of academic impact, for papers by Harley I. Kornblum Breakdown of academic impact, for papers by Rossella Galli Breakdown of academic impact, for papers by Angelo L. Vescovi Breakdown of academic impact, for papers by William B. Stallcup Breakdown of academic impact, for papers by Brent A. Reynolds Breakdown of academic impact, for papers by Karl H. Plate Breakdown of academic impact, for papers by Scott R. VandenBerg Breakdown of academic impact, for papers by Nader Sanai Breakdown of academic impact, for papers by Dennis A. Steindler
Rankless by CCL
2026